pharma · Clear Cell Renal Cell Carcinoma · Cushing s Syndrome
Peking University Biologics
Peking University Third Hospital
Peking University Third is a pharma organization headquartered in CN. Primary therapeutic focus areas include Clear Cell Renal Cell Carcinoma, Cushing s Syndrome, Esophageal Cancer, Prostate Cancer, Aged. NovaPharmaNews
仙霞路, 319号, 上海市, 长宁区, CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 仙霞路, 319号, 上海市, 长宁区, CN
- Founded
- 2018
- Employees
- 8
- Programs
- 15
- Drugs
- 25
- Patents
- 0
Dexmedetomidine
Approved · small molecule · Aged
Dexmedetomidine for Aged is a Approved program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).
Internal code 2017[13]
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Peking University Third Hospital
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Aged
- Status
- completed
- Trials
- 1